{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:28:07Z","timestamp":1785788887333,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"DOI":"10.1038\/s44259-024-00041-8","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T13:02:45Z","timestamp":1725973365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic mutations in Cryptococcus neoformans pyrimidine salvage pathway enzymes contribute to reduced susceptibility against 5-fluorocytosine"],"prefix":"10.1038","volume":"2","author":[{"given":"Fatima Zohra","family":"Delma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Cabrera-Orefice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-6250","authenticated-orcid":false,"given":"Jordy","family":"Coolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M. S.","family":"Al-Hatmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J. G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung J.","family":"Kwon-Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybren","family":"de Hoog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-0778","authenticated-orcid":false,"given":"Jochem B.","family":"Buil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"41_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","volume":"46","author":"A Vermes","year":"2000","unstructured":"Vermes, A., Guchelaar, H. J. & Dankert, J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 46, 171\u2013179 (2000).","journal-title":"J. Antimicrob. Chemother."},{"key":"41_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect, J. R. et al. Clinical practice guidelines for the management of cryptococcal disease: update by the Infectious Diseases Society of America. Clin. Infect. Dis. 50, 291\u2013322 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"41_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1469-0691.2008.02021.x","volume":"14","author":"A Gomez-Lopez","year":"2008","unstructured":"Gomez-Lopez, A. et al. In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin. Microbiol Infect. 14, 727\u2013730 (2008).","journal-title":"Clin. Microbiol Infect."},{"key":"41_CR4","doi-asserted-by":"crossref","unstructured":"Delma, F. Z. et al. Molecular mechanisms of 5-fluorocytosine resistance in yeasts and filamentous Fungi. J. Fungi Basel 7, 909 (2021).","DOI":"10.3390\/jof7110909"},{"key":"41_CR5","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1128\/AAC.00605-10","volume":"54","author":"TD Edlind","year":"2010","unstructured":"Edlind, T. D. & Katiyar, S. K. Mutational analysis of flucytosine resistance in Candida glabrata. Antimicrob. Agents Chemother. 54, 4733\u20134738 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41_CR6","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1128\/AAC.48.11.4377-4386.2004","volume":"48","author":"WW Hope","year":"2004","unstructured":"Hope, W. W., Tabernero, L., Denning, D. W. & Anderson, M. J. Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob. Agents Chemother. 48, 4377\u20134386 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41_CR7","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1128\/AAC.00880-08","volume":"53","author":"M Florent","year":"2009","unstructured":"Florent, M. et al. Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae. Antimicrob. Agents Chemother. 53, 2982\u20132990 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/mmy\/myx135","volume":"56","author":"K Vu","year":"2018","unstructured":"Vu, K. et al. Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway. Med mycol. 56, 857\u2013867 (2018).","journal-title":"Med mycol."},{"key":"41_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1128\/EC.05236-11","volume":"11","author":"MH Song","year":"2012","unstructured":"Song, M. H. et al. A flucytosine-responsive Mbp1\/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans. Eukaryot. cell 11, 53\u201367 (2012).","journal-title":"Eukaryot. cell"},{"key":"41_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13890-z","volume":"11","author":"RB Billmyre","year":"2020","unstructured":"Billmyre, R. B., Applen Clancey, S., Li, L. X., Doering, T. L. & Heitman, J. 5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus. Nat. Commun. 11, 127 (2020).","journal-title":"Nat. Commun."},{"key":"41_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23745-1","volume":"12","author":"YC Chang","year":"2021","unstructured":"Chang, Y. C. et al. Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci. Nat. Commun. 12, 3418 (2021).","journal-title":"Nat. Commun."},{"key":"41_CR12","doi-asserted-by":"crossref","unstructured":"Montoya, M. C., Magwene, P. M. & Perfect, J. R. Associations between cryptococcus genotypes, phenotypes, and clinical parameters of human disease: a review. J. Fungi Basel 7, 260 (2021).","DOI":"10.3390\/jof7040260"},{"key":"41_CR13","doi-asserted-by":"publisher","first-page":"e00238","DOI":"10.1128\/mSphere.00238-17","volume":"2","author":"F Hagen","year":"2017","unstructured":"Hagen, F. et al. Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus Genus. mSphere 2, e00238\u201317 (2017).","journal-title":"mSphere"},{"key":"41_CR14","doi-asserted-by":"publisher","first-page":"e02261","DOI":"10.1128\/AAC.02261-19","volume":"64","author":"FZ Delma","year":"2020","unstructured":"Delma, F. Z. et al. Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST broth microdilution reference methods for in vitro antifungal susceptibility testing of Cryptococcus neoformans. Antimicrob. Agents Chemother. 64, e02261\u201319 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-61779-501-5_9","volume":"835","author":"M Arentshorst","year":"2012","unstructured":"Arentshorst, M., Ram, A. F. & Meyer, V. Using non-homologous end-joining-deficient strains for functional gene analyses in filamentous fungi. Methods Mol. Biol. 835, 133\u2013150 (2012).","journal-title":"Methods Mol. Biol."},{"key":"41_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. (Austin) 6, 80\u201392 (2012).","journal-title":"Fly. (Austin)"},{"key":"41_CR17","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1093\/bioinformatics\/btv271","volume":"31","author":"SN Gardner","year":"2015","unstructured":"Gardner, S. N., Slezak, T. & Hall, B. G. kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome. Bioinformatics 31, 2877\u20132878 (2015).","journal-title":"Bioinformatics"},{"key":"41_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1534\/genetics.117.203836","volume":"207","author":"J Rhodes","year":"2017","unstructured":"Rhodes, J. et al. Tracing genetic exchange and biogeography of Cryptococcus neoformans var. grubii at the global population level. Genetics 207, 327\u2013346 (2017).","journal-title":"Genetics"},{"key":"41_CR19","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 49, W293\u2013W296 (2021).","journal-title":"Nucleic Acids Res."},{"key":"41_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers, F. et al. Fast, scalable generation of high\u2010quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"41_CR21","doi-asserted-by":"publisher","first-page":"W350","DOI":"10.1093\/nar\/gky300","volume":"46","author":"CH Rodrigues","year":"2018","unstructured":"Rodrigues, C. H., Pires, D. E. & Ascher, D. B. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 46, W350\u2013W355 (2018).","journal-title":"Nucleic Acids Res."},{"key":"41_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"41_CR23","doi-asserted-by":"publisher","first-page":"e1078","DOI":"10.1371\/journal.pone.0001078","volume":"2","author":"T von der Haar","year":"2007","unstructured":"von der Haar, T. Optimized protein extraction for quantitative proteomics of yeasts. PLoS ONE 2, e1078 (2007).","journal-title":"PLoS ONE"},{"key":"41_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23919-x","volume":"12","author":"F Evers","year":"2021","unstructured":"Evers, F. et al. Composition and stage dynamics of mitochondrial complexes in Plasmodium falciparum. Nat. Commun. 12, 3820 (2021).","journal-title":"Nat. Commun."},{"key":"41_CR25","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"41_CR26","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1093\/bioinformatics\/btz025","volume":"35","author":"J Van Strien","year":"2019","unstructured":"Van Strien, J. et al. COmplexome Profiling ALignment (COPAL) reveals remodeling of mitochondrial protein complexes in Barth syndrome. Bioinformatics 35, 3083\u20133091 (2019).","journal-title":"Bioinformatics"},{"key":"41_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"41_CR28","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1093\/emboj\/17.12.3219","volume":"17","author":"MA Schumacher","year":"1998","unstructured":"Schumacher, M. A. et al. Crystal structures of Toxoplasma gondii uracil phosphoribosyltransferase reveal the atomic basis of pyrimidine discrimination and prodrug binding. EMBO J. 17, 3219\u20133232 (1998).","journal-title":"EMBO J."},{"key":"41_CR29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/mmi.14565","volume":"114","author":"A Bermas","year":"2020","unstructured":"Bermas, A. & Geddes-McAlister, J. Combatting the evolution of antifungal resistance in Cryptococcus neoformans. Mol. Microbiol 114, 721\u2013734 (2020).","journal-title":"Mol. Microbiol"},{"key":"41_CR30","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1128\/AAC.00607-09","volume":"53","author":"BA McManus","year":"2009","unstructured":"McManus, B. A., Moran, G. P., Higgins, J. A., Sullivan, D. J. & Coleman, D. C. A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 53, 4678\u20134685 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11046-010-9342-1","volume":"171","author":"P Vandeputte","year":"2011","unstructured":"Vandeputte, P. et al. Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata. Mycopathologia 171, 11\u201321 (2011).","journal-title":"Mycopathologia"},{"key":"41_CR32","doi-asserted-by":"publisher","first-page":"e00230","DOI":"10.1128\/mBio.00230-20","volume":"11","author":"L Bir\u0161tonas","year":"2020","unstructured":"Bir\u0161tonas, L. et al. Multiplex genetic engineering exploiting pyrimidine salvage pathway-based endogenous counterselectable markers. mBio 11, e00230\u201320 (2020).","journal-title":"mBio"},{"key":"41_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/10408418709104447","volume":"15","author":"WL Whelan","year":"1987","unstructured":"Whelan, W. L. The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans. Crit. Rev. Microbiol. 15, 45\u201356 (1987).","journal-title":"Crit. Rev. Microbiol."},{"key":"41_CR34","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-024-00041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-024-00041-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-024-00041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T13:23:40Z","timestamp":1725974620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-024-00041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1038\/s44259-024-00041-8","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"30 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.E.V. reports grants from Gilead Sciences, Mundipharma, Pfizer and F2G, honoraria for lectures for Gilead Sciences and Pfizer and participation in advisory board for F2G, outside the submitted work. All payments were invoiced by the institution. J.B.B. reports grant from Gilead Sciences and F2G, lectures for Gilead Sciences and Pfizer and advisory board for Gilead Sciences outside the submitted work. All payments were invoiced by the institution. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}